Key result
Implantation of the leadless ultrasound-based WiCS-LV pacing system was feasible in 3 heart failure patients, increasing mean LV ejection fraction from 23.7% to 39% (P<0.017) at 6 months.
Why the study?
Does a leadless ultrasound-based cardiac stimulation pacing system improve LVEF and symptoms in heart failure patients requiring CRT?
Population
3 heart failure patients with NYHA class III-IV and mean LVEF 23.7 ± 3.4%
Design
Case_series
Follow-up
6 months
Authors
Loading...
May inform novel CRT delivery; hypothesis-generating and should not yet change practice.
Case Report (n=3)
Does a leadless ultrasound-based cardiac stimulation pacing system improve LVEF and symptoms in heart failure patients requiring CRT?
p-value: p=<0.017
First-in-man implantation of a leadless ultrasound-based LV endocardial pacing system demonstrated feasibility, safety, and short-term improvement in LVEF and symptoms in heart failure patients.
Auricchio et al. (2013) conducted a case report in heart failure (n=3). WiCS-LV system (leadless ultrasound-based cardiac stimulation pacing system) was evaluated on Left ventricular ejection fraction (p=<0.017). Implantation of the leadless ultrasound-based WiCS-LV pacing system was feasible in 3 heart failure patients, increasing mean LV ejection fraction from 23.7% to 39% (P<0.017) at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: